Affect of RT-CGMS as Part of Clinical Care in Type 1 Diabetes Mellitus Patients
Prospective Short and Long Term Follow up of Pediatric Diabetes Mellitus Patients Receiving RT-CGMS as Part of National Clinical Care
Sponsor: Assaf-Harofeh Medical Center
Listed as NCT01525784, this observational or N/A phase trial focuses on Hypoglycemia and Type 1 Diabetes Mellitus and remains ongoing. Sponsored by Assaf-Harofeh Medical Center, it has been updated 7 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Unknown
-
Sep 2024 — Sep 2025 [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status
▶ Show 2 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Unknown Status
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Unknown Status NA
First recorded
Feb 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Assaf-Harofeh Medical Center
- Kaplan Medical Center
- Soroka University Medical Center
- The Chaim Sheba Medical Center
- Wolfson Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .